$603 Million is the total value of AUXIER ASSET MANAGEMENT's 164 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | CytoDyn, Inc | $0 | – | -14,300 | -100.0% | -0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-18
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UnitedHealth Group Inc. | 42 | Q3 2023 | 8.0% |
| Microsoft Corp. | 42 | Q3 2023 | 6.5% |
| Philip Morris International | 42 | Q3 2023 | 4.9% |
| Pepsico Inc. | 42 | Q3 2023 | 3.6% |
| Kroger Co. | 42 | Q3 2023 | 3.9% |
| Bank of New York Mellon Corp | 42 | Q3 2023 | 3.2% |
| Johnson & Johnson | 42 | Q3 2023 | 3.0% |
| Mastercard Inc. | 42 | Q3 2023 | 3.7% |
| Merck & Co.Inc. New | 42 | Q3 2023 | 2.4% |
| Molson Coors Brewing Co | 42 | Q3 2023 | 4.0% |
View AUXIER ASSET MANAGEMENT's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-08 |
| 13F-HR | 2024-02-22 |
| 13F-HR | 2023-11-21 |
| 13F-HR | 2023-08-17 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-17 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-03-01 |
View AUXIER ASSET MANAGEMENT's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.